A double-blind, randomized, placebo-controlled study assessing polarity-analysis-guided individualized homeopathic therapy for chronic primary heel pain in adults.

Published: 3 September 2026| Version 4 | DOI: 10.17632/n4xdw5zbxf.4
Contributors:
,
,
,
,
,
,
,
,

Description

Background: Chronic primary heel pain is a debilitating condition that significantly restricts mobility and daily activities. Despite conservative treatments providing only modest long-term benefits in the context of high chronicity, individualized homeopathic medicines (IHMs) show preliminary promise. However, the clinical efficacy of polarity analysis (PA), based on Boenninghausen’s method, a refined repertorization method enhancing precision in prescription, remains unevaluated in this condition. Methods: In this double-blind, 2:1 randomized, placebo-controlled trial (n = 74), PAderived IHMs, selected from Boenninghausen’s module (requiring ≥5 polar symptoms and ≥10 potentially relevant remedies), were compared against placebo over 3 months. The primary outcome was the Foot Function Index (FFI) total score (comprising pain, disability, and activity-limitation subscales); the secondary outcome was the Measure Yourself Medical Outcome Profile (MYMOP2). Intention-to-treat analysis employed Functional Data Analysis (FDA) with B-spline smoothing and permutation tests for recovery trajectories, Generalized Estimating Equations (GEE) adjusted for baseline covariates, and Multivariate Linear Mixed Models (MLMM) for group differences. Results: FDA showed monotonic improvement with IHMs versus flat placebo trajectories, diverging by week 3 (p < 0.001). GEE found the placebo ended 55.03 FFI points higher (p < 0.001). Findings were consistently robust across sensitivity tests and subgroups. Bryonia alba (n = 13, 17.6%), Sulphur (n = 8, 10.8%), and Calcarea carbonica (n = 8, 10.8%) were the most frequently used IHMs. The five most effective remedies were Calcarea carbonica, Bryonia alba, Rhus toxicodendron, Causticum, and Staphysagria macrosperma. Conclusion: IHMs guided by PA demonstrated superior and clinically meaningful recovery compared with placebo in patients with chronic primary heel pain.

Files

Institutions

Categories

Placebo, Homeopathy, Randomized Controlled Trial, Heel Pain

Licence